Filing Details
- Accession Number:
- 0000899243-19-017457
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-19 17:58:23
- Reporting Period:
- 2017-04-27
- Accepted Time:
- 2019-06-19 17:58:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283292 | A David Ramsay | 6836 Bee Cave Road, Building Iii Suite 200 Austin TX 78746 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-27 | 1,142 | $0.00 | 23,570 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-06-17 | 10,000 | $2.39 | 33,570 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-17 | 10,000 | $2.38 | 43,570 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-17 | 5,000 | $2.37 | 48,570 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-18 | 5,000 | $2.36 | 53,570 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-18 | 10,215 | $2.35 | 63,785 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2017-04-27 | 1,142 | $0.00 | 1,142 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- The vesting of the restricted stock units occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings.
- Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The amount reported reflects the 70-for-one reverse stock split implemented by the issuer on April 27, 2017.
- The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement.
Billionaire Hedge Funds
